Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren Schonfeld

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics|September 18, 2003
Cost-effectiveness league tables: valuable guidance for decision makers?Josephine Mauskopf, Frans Rutten, Warren Schonfeld
Epilepsy & Behavior : E&B|February 21, 2012
Trigger self-control and seizure arrest in the Andrews/Reiter behavioral approach to epilepsy: a retrospective analysis of seizure frequencyRosa Michaelis, Warren Schonfeld, Siegward-M Elsas
Clinicoeconomics and Outcomes Research : CEOR|January 29, 2014
Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancerKimberly Mislick, Warren Schonfeld, Carolyn Bodnar, et al.
Clinical Therapeutics|June 17, 2008
Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantationWarren Schonfeld, J Wang Cheng, Kuo B Tong, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics|September 18, 2003
Cost-effectiveness league tables: valuable guidance for decision makers?Josephine Mauskopf, Frans Rutten, Warren Schonfeld
Epilepsy & Behavior : E&B|February 21, 2012
Trigger self-control and seizure arrest in the Andrews/Reiter behavioral approach to epilepsy: a retrospective analysis of seizure frequencyRosa Michaelis, Warren Schonfeld, Siegward-M Elsas
Clinicoeconomics and Outcomes Research : CEOR|January 29, 2014
Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancerKimberly Mislick, Warren Schonfeld, Carolyn Bodnar, et al.
Clinical Therapeutics|June 17, 2008
Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantationWarren Schonfeld, J Wang Cheng, Kuo B Tong, et al.
Pageof 1